rs763717023
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_024537.4(CARS2):c.1505T>C(p.Leu502Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000963 in 1,453,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L502M) has been classified as Uncertain significance.
Frequency
Consequence
NM_024537.4 missense
Scores
Clinical Significance
Conservation
Publications
- combined oxidative phosphorylation defect type 27Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
- mitochondrial diseaseInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.0000593  AC: 14AN: 236114 AF XY:  0.0000467   show subpopulations 
GnomAD4 exome  AF:  0.00000963  AC: 14AN: 1453870Hom.:  0  Cov.: 33 AF XY:  0.00000830  AC XY: 6AN XY: 722700 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 27    Uncertain:2 
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 502 of the CARS2 protein (p.Leu502Pro). This variant is present in population databases (rs763717023, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with CARS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 569707). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 0.03% (13/33610) (https://gnomad.broadinstitute.org/variant/13-111294780-A-G?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:569707). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at